Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ NFRKB Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA552389
Description
Immunogen sequence: KSSSGVLLVS SPTMPHLGTM LSPASSQTAP SSQAAARVVS HSGSAGLSQV RVVAQPSLPA VPQQSGGPAQ TLPQMPAGPQ IRVPATATQT KVVPQTVMAT VPVKAQTTAA TV Highest antigen sequence identity to the following orthologs: Mouse - 87%, Rat - 87%.
NFRKB (nuclear factor related to kappa-B-binding protein) was first identified as a factor that could bind a variant NF-kappa B site in the interleukin-2 receptor alpha (IL-2R alpha) gene. NFRKB appears to be a transcription factor central to immune cell development. Evidence of this comes from the identification of NFRKB as an amplified gene in several cases of acute myeloid leukemia. Additionally, in another clinical case, a partial deletion of the chromosomal region that includes NFRKB is shown to be associated with combined cellular immunodeficiency.
Specifications
NFRKB | |
Polyclonal | |
Unconjugated | |
NFRKB | |
A530090G11Rik; DNA-binding protein R kappa B; DNA-binding protein R kappa-B; INO80 complex subunit G; INO80G; NFRKB; nuclear factor related to kappa B binding protein; nuclear factor related to kappaB binding protein; nuclear factor related to kappa-B-binding protein | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
4798 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin), Immunocytochemistry | |
0.2 mg/mL | |
PBS with 40% glycerol and 0.02% sodium azide; pH 7.2 | |
Q6P4R8 | |
NFRKB | |
Recombinant protein corresponding to Human NFRKB. Recombinant protein control fragment (Product #RP-89400). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction